| http://dbpedia.org/ontology/abstract
|
إيتوليزوماب جسم مضاد وحيد النسيلة مأنسن طورته الهندية لعلاج الصداف. حصلت بيوكون على موافقة لتسويقه في الهند.
, Itolizumab (INN, trade name Alzumab) is a ‘first in class’ humanized IgG1 monoclonal antibody developed by Biocon and the Center of Molecular Immunology (CIM), Havana.
|
| http://dbpedia.org/ontology/alternativeName
|
Alzumab
|
| http://dbpedia.org/ontology/casNumber
|
1116433-11-4
|
| http://dbpedia.org/ontology/fdaUniiCode
|
XQQ2RHV14N
|
| http://dbpedia.org/ontology/kegg
|
D12426
|
| http://dbpedia.org/ontology/wikiPageID
|
33052137
|
| http://dbpedia.org/ontology/wikiPageLength
|
4623
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1124062626
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Co-stimulation +
, http://dbpedia.org/resource/COVID-19 +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Center_of_Molecular_Immunology +
, http://dbpedia.org/resource/Psoriasis_Area_and_Severity_Index +
, http://dbpedia.org/resource/Category:Orphan_drugs +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/CD6 +
, http://dbpedia.org/resource/Biocon +
, http://dbpedia.org/resource/Cytokine +
, http://dbpedia.org/resource/Drugs_Controller_General_of_India +
, http://dbpedia.org/resource/T_cell +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Psoriasis +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/casNumber
|
1116433
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/kegg
|
D12426
|
| http://dbpedia.org/property/legalStatus
|
Approved in India
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/source
|
zu
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/CD6 +
|
| http://dbpedia.org/property/tradename
|
Alzumab
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
XQQ2RHV14N
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
458270653
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Monoclonal-antibody-stub +
, http://dbpedia.org/resource/Template:Monoclonals_for_immune_system +
, http://dbpedia.org/resource/Template:Antineoplastic-drug-stub +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Category:Orphan_drugs +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/%E2%80%98 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Itolizumab?oldid=1124062626&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Itolizumab +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q6094826 +
, http://rdf.freebase.com/ns/m.0h551rm +
, http://ar.dbpedia.org/resource/%D8%A5%D9%8A%D8%AA%D9%88%D9%84%D9%8A%D8%B2%D9%88%D9%85%D8%A7%D8%A8 +
, http://yago-knowledge.org/resource/Itolizumab +
, https://global.dbpedia.org/id/4oEp3 +
, http://dbpedia.org/resource/Itolizumab +
|
| rdf:type |
http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Thing100002452 +
, http://dbpedia.org/class/yago/Molecule114682133 +
, http://dbpedia.org/class/yago/Unit109465459 +
, http://dbpedia.org/class/yago/Macromolecule114944888 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/MonoclonalAntibody115029781 +
, http://dbpedia.org/class/yago/WikicatMonoclonalAntibodies +
, http://dbpedia.org/class/yago/Protein114728724 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/Person +
, http://dbpedia.org/class/yago/Antibody115027189 +
|
| rdfs:comment |
إيتوليزوماب جسم مضاد وحيد النسيلة مأنسن طورته الهندية لعلاج الصداف. حصلت بيوكون على موافقة لتسويقه في الهند.
, Itolizumab (INN, trade name Alzumab) is a ‘first in class’ humanized IgG1 monoclonal antibody developed by Biocon and the Center of Molecular Immunology (CIM), Havana.
|
| rdfs:label |
Itolizumab
, إيتوليزوماب
|
